.png){kind=small}
.png){kind=small}
BackTable / Tumor Board / Topic / Procedure
Tyrosine Kinase Inhibitor (TKI)
Learn more on the BackTable Tumor Board Podcast
BackTable is a knowledge resource for physicians by physicians. Get practical advice on Tyrosine Kinase Inhibitor (TKI) and how to build your practice by listening to the BackTable Tumor Board Podcast, reading exclusing BackTable Articles, and following the work of our Contributors.
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Tyrosine Kinase Inhibitor (TKI) Podcasts
Listen to leading physicians discuss tyrosine kinase inhibitor (tki) on the BackTable Tumor Board Podcast. Get tips, tricks, and expert guidance from your peers and level up your practice.
Episode #3
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative to tyrosine kinase inhibitors and chemotherapy, making it an exciting time to be practicing oncology. In this episode, Dr. Tyler Sandow interviews oncology experts about the landscape of advanced hepatocellular carcinoma (HCC) and the current state of immunotherapy treatments. He is joined by medical oncologists Dr. Jonathan Mizrah, Dr. Lingling Du, and Dr. Adam Burgoyne, as well as interventional oncologist Dr. Zachary Berman.
Disclaimer: The Materials available on https://www.BackTable.com/ are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Podcasts
